Summary
This work investigates whether age moderates the effectiveness of blue light therapy on PTSD-related sleep symptom severity, framed within a broader model of allostasis and allostatic load involving hippocampal, amygdalar, and prefrontal systems. For lighting practitioners, it suggests that age may be an important variable when designing light-based interventions for trauma-affected populations, potentially requiring tailored protocols for different age groups.
Categories
Mood & Mental Wellness: The paper examines blue light therapy as a treatment for PTSD sleep symptoms, with potential age-moderated effects on stress-related neural circuitry.
Sleep & Circadian Health: PTSD sleep symptom severity is a central focus, with blue light therapy explored as an intervention affecting circadian-related sleep disturbances.
Author(s)
KH Oxley
Publication Year
2022
Related Publications
Mood & Mental Wellness
- The twoāprocess model of sleep regulation: a reappraisal
- Protecting the melatonin rhythm through circadian healthy light exposure
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- The role of daylight for humans: gaps in current knowledge
Sleep & Circadian Health
- Phototransduction by retinal ganglion cells that set the circadian clock
- The mammalian circadian timing system: organization and coordination of central and peripheral clocks
- The twoāprocess model of sleep regulation: a reappraisal
- Melanopsin is required for non-image-forming photic responses in blind mice
- Strange vision: ganglion cells as circadian photoreceptors